Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.27
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.27
CLLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Apr 2016 10:26

RNS Number : 6295U
Carillion PLC
08 April 2016
 

Carillion plc

 

Carillion Deferred Bonus Plan and the

Carillion plc 2014 Long Term Incentive Plan

(known as the Leadership Equity Award Plan (LEAP))

 

1. Carillion Deferred Bonus Plan

 

The following Persons Discharging Managerial Responsibilities (PDMRs) were awarded on 7th April 2016 the following share awards under the Carillion Deferred Bonus Plan:-

Maximum No. of Ordinary

Shares of 50p each*

Release date

Richard Howson

Group Chief Executive

51,081

7th April 2019

Richard Adam

Group Finance Director

37,493

7th April 2019

Simon Buttery

MD Carillion Canada

8,739

7th April 2017

Shaun Carter

Group International and Development Director

7,653

7th April 2017

Janet Dawson

Group HR Director

13,298

7th April 2017

Adam Green

MD Carillion Construction Services

19,771

7th April 2017

Andy Jones

MD Carillion MENA

8,631

7th April 2017

Zafar Khan

Group Financial Controller

17,744

7th April 2017

John Platt

MD Strategic Growth

6,015

7th April 2017

Richard Tapp

Company Secretary

16,181

7th April 2017

Nigel Taylor

MD Carillion Services

17,650

7th April 2017

* 0.012% of the issued share capital or less.

 

The shares will be transferred to the PDMRs in 2017 or 2019 as shown above, subject to them remaining in employment or leaving in permitted circumstances.

 

2. Leadership Equity Award Plan (LEAP)

 

Awards were made on 7th April 2016 under the LEAP as shown in the table below. The number of shares vesting will be subject to achievement of the performance target which is based on earnings per share growth, cash conversion and strategic targets over a 3 year performance period.

 

 

 

 

 

Maximum No. of Ordinary Shares

of 50p each*

Richard Howson

Group Chief Executive

319,024

Richard Adam

Group Finance Director

240,418

Simon Buttery

MD Carillion Canada

60,105

Shaun Carter

Group International and Development Director

52,265

Janet Dawson

Group HR Director

57,491

Adam Green

MD Carillion Construction Services

109,756

Andy Jones

MD Carillion MENA

52,265

Zafar Khan

Group Financial Controller

84,930

Richard Tapp

Company Secretary

65,331

Nigel Taylor

MD Carillion Services

104,530

 

*0.074% of the issued share capital or less.

 

 

Tim George

Deputy Company Secretary

8th April 2016

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEANLPEALKEEF
Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.